Skip to main content
Genitourinary Medicine logoLink to Genitourinary Medicine
. 1987 Apr;63(2):95–97. doi: 10.1136/sti.63.2.95

Netilmicin: new approach to treating gonorrhoea.

J Söltz-Szöts, W Kopp, W Gebhart, J Thurner, C Poitschek
PMCID: PMC1194025  PMID: 3583277

Abstract

Resistance and side effects to antibiotics or other chemotherapeutic agents are the main limiting factors in the treatment of gonorrhoea. As no such side effects have been reported with a new aminoglycoside, netilmicin, the therapeutic efficiency of this substance was evaluated in 1200 patients (690 women, 510 men) with uncomplicated gonorrhoea, who each received a single dose of 300 mg netilmicin by intramuscular injection. Efficacy of treatment was assessed by smear microscopy and culture, which gave results in all 1200 patients. No serious side effects were reported. These results indicate that netilmicin is an extraordinarily safe and efficient agent for treating uncomplicated gonorrhoea.

Full text

PDF
95

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashford W. A., Potts D. W., Adams H. J., English J. C., Johnson S. R., Biddle J. W., Thornsberry C., Jaffe H. W. Spectinomycin-resistant penicillinase-producing Neisseria gonorrhoeae. Lancet. 1981 Nov 7;2(8254):1035–1037. doi: 10.1016/s0140-6736(81)91227-7. [DOI] [PubMed] [Google Scholar]
  2. Davies J., Courvalin P. Mechanisms of resistance to aminoglycosides. Am J Med. 1977 Jun;62(6):868–872. doi: 10.1016/0002-9343(77)90654-4. [DOI] [PubMed] [Google Scholar]
  3. Eichmann A. Penizillinresistenz der Gonorrhö in Europa. Hautarzt. 1983 Nov;34(11):537–538. [PubMed] [Google Scholar]
  4. Idsoe O., Guthe T., Willcox R. R., de Weck A. L. Nature and extent of penicillin side-reactions, with particular reference to fatalities from anaphylactic shock. Bull World Health Organ. 1968;38(2):159–188. [PMC free article] [PubMed] [Google Scholar]
  5. Kahlmeter G. Netilmicin: clinical pharmacokinetics and aspects on dosage schedules. An overview. Scand J Infect Dis Suppl. 1980;Suppl 23:74–81. [PubMed] [Google Scholar]
  6. Korting H. C. Zephalosporin-Allergie und Zephalosporin-Penizillin-Kreuzallergie unter besonderer Berücksichtigung für die venerologische Therapie bedeutsamer anaphylaktischer Reaktionen. Hautarzt. 1984 May;35(5):225–229. [PubMed] [Google Scholar]
  7. Patterson R., Anderson J. Allergic reactions to drugs and biologic agents. JAMA. 1982 Nov 26;248(20):2637–2645. [PubMed] [Google Scholar]
  8. Perine P. L., Thornsberry C., Schalla W., Biddle J., Siegel M. S., Wong K. H., Thompson S. E. Evidence for two distinct types of penicillinase-producing Neisseria gonorrhoeae. Lancet. 1977 Nov 12;2(8046):993–995. doi: 10.1016/s0140-6736(77)92891-4. [DOI] [PubMed] [Google Scholar]
  9. Petzoldt D., Hofmann H., Wiebelt H. Behandlung der Gonorrhö in der dermatologischen Praxis. Ergebnise einer Umfrage. Hautarzt. 1982 Nov;33(11):595–597. [PubMed] [Google Scholar]
  10. Sanders C. C., Sanders W. E., Jr, Goering R. V. In vitro studies with Sch 21420 and Sch 22591: activity in comparison with six other aminoglycosides and synergy with penicillin against enterococci. Antimicrob Agents Chemother. 1978 Aug;14(2):178–184. doi: 10.1128/aac.14.2.178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Söltz-Szöts J., Kopp W., Thurner J., Poitschek C., Stary A. Kritische Bemerkungen zur Gonorrhoe-Therapie: Netilmicin. Z Hautkr. 1985 Nov 1;60(21):1665-6, 1671-4, 1679-81. [PubMed] [Google Scholar]
  12. Terho P. Chlamydia trachomatis in gonococcal and postgonococcal urethritis. Br J Vener Dis. 1978 Oct;54(5):326–329. doi: 10.1136/sti.54.5.326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Vogt H. Kreuzallergie von Cephaloridin, Cephalothin und Penicillin. Hautarzt. 1969 Sep;20(9):407–408. [PubMed] [Google Scholar]

Articles from Genitourinary Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES